Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease

[1]  S. Stanojevic,et al.  ERS/ATS technical standard on interpretive strategies for routine lung function tests , 2021, European Respiratory Journal.

[2]  T. Gille,et al.  Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency , 2021, European Respiratory Review.

[3]  M. Coertjens,et al.  Factors influencing self-selected walking speed in fibrotic interstitial lung disease , 2021, Scientific Reports.

[4]  C. Williams,et al.  Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study , 2021, BMJ Open Respiratory Research.

[5]  C. Sharp,et al.  The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review , 2020, ERJ Open Research.

[6]  R. Casaburi,et al.  ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases , 2019, European Respiratory Review.

[7]  C. Williams,et al.  Validity of the Supramaximal Test to Verify Maximal Oxygen Uptake in Children and Adolescents. , 2019, Pediatric exercise science.

[8]  Z. Saynor,et al.  CARDIOPULMONARY EXERCISE TESTING WITH SUPRAMAXIMAL VERIFICATION PRODUCES A SAFE AND VALID ASSESSMENT OF V̇O2max IN PEOPLE WITH CYSTIC FIBROSIS. , 2018, Journal of applied physiology.

[9]  C. Williams,et al.  Analysis of oxygen uptake efficiency parameters in young people with cystic fibrosis , 2018, European Journal of Applied Physiology.

[10]  R. Szczesniak,et al.  Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data , 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  E. Wilson,et al.  Repeatability and Meaningful Change of CPET Parameters in Healthy Subjects , 2017, Medicine and science in sports and exercise.

[12]  M. Bonini,et al.  Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing , 2017, European Respiratory Review.

[13]  D. Poole,et al.  Measurement of the maximum oxygen uptake V̇o2max: V̇o2peak is no longer acceptable. , 2017, Journal of applied physiology.

[14]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[15]  Ashutosh Kumar Singh,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[16]  José Oliveira,et al.  The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis , 2016, Respiratory Care.

[17]  A. Hughes,et al.  Oxygen Uptake Efficiency Slope and Breathing Reserve, Not Anaerobic Threshold, Discriminate Between Patients With Cardiovascular Disease Over Chronic Obstructive Pulmonary Disease , 2016, JACC. Heart failure.

[18]  Katherine Spinks,et al.  The diagnosis and management of interstitial lung diseases , 2015, BMJ : British Medical Journal.

[19]  C. Williams,et al.  Reproducibility of maximal cardiopulmonary exercise testing for young cystic fibrosis patients. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[20]  C. Williams,et al.  A protocol to determine valid V˙O2max in young cystic fibrosis patients. , 2013, Journal of science and medicine in sport.

[21]  A. Kotanidou,et al.  The Role of Cardiopulmonary Exercise Test in IPF Prognosis , 2013, Pulmonary medicine.

[22]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[23]  Joyce S Lee,et al.  A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.

[24]  J. E. Hansen,et al.  Oxygen uptake efficiency plateau best predicts early death in heart failure. , 2012, Chest.

[25]  J. E. Hansen,et al.  Oxygen uptake efficiency plateau: physiology and reference values , 2012, European Journal of Applied Physiology.

[26]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[27]  C. Willíams,et al.  Establishing maximal oxygen uptake in young people during a ramp cycle test to exhaustion , 2009, British Journal of Sports Medicine.

[28]  F. Martinez,et al.  The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[29]  David C. Poole,et al.  Validity of criteria for establishing maximal O2 uptake during ramp exercise tests , 2008, European Journal of Applied Physiology.

[30]  Mary Ann Peberdy,et al.  The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. , 2007, Journal of cardiac failure.

[31]  B J Whipp,et al.  A test to establish maximum O2 uptake despite no plateau in the O2 uptake response to ramp incremental exercise. , 2006, Journal of applied physiology.

[32]  M. Bartels,et al.  Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. , 2005, Respiratory medicine.

[33]  N. Seersholm,et al.  Standardised mortality rates in females and males with COPD and asthma , 2005, European Respiratory Journal.

[34]  W. Travis,et al.  Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[35]  J. E. Hansen,et al.  Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. , 2004, Chest.

[36]  H. Collard,et al.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[37]  R. Ross,et al.  ATS/ACCP statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.

[38]  C. Gallagher,et al.  Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. , 1999, Chest.

[39]  E. Russi,et al.  Effect of training on repeatability of cardiopulmonary exercise performance in normal men and women. , 1997, Medicine and science in sports and exercise.

[40]  C. Gallagher,et al.  Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease. , 1993, Thorax.

[41]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.

[42]  Jacob Cohen,et al.  A power primer. , 1992, Psychological bulletin.

[43]  B. Whipp,et al.  A new method for detecting anaerobic threshold by gas exchange. , 1986, Journal of applied physiology.

[44]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[45]  L. Makrides,et al.  Normal standards for an incremental progressive cycle ergometer test. , 1985, The American review of respiratory disease.

[46]  A. Batterham,et al.  Spreadsheets for Analysis of Validity and Reliability , 2015 .

[47]  F. Martinez,et al.  ATS/ACCP Statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.

[48]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[49]  G. Borg.  Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.